<html>
<head>
<title>Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish – TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">Prellis Biologics 筹集了 1450 万美元，在 TechCrunch 上首次推出了“人类免疫系统”</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2021/12/15/prellis-biologics-raises-14-5m-debuts-a-human-immune-system-in-a-dish/amp/">https://web.archive.org/web/https://techcrunch.com/2021/12/15/prellis-biologics-raises-14-5m-debuts-a-human-immune-system-in-a-dish/amp/</a></blockquote><div><div class="content">

			
	
		
		

		<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg 1936w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=150,103 150w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=300,206 300w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=768,527 768w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=680,466 680w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=1536,1054 1536w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=50,34 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/bebbef30449eb86ad207ede3244269d9.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" loading="lazy" srcset="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg 1936w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=150,103 150w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=300,206 300w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=768,527 768w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=680,466 680w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=1536,1054 1536w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?resize=50,34 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-769725243.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong>pixological studio/科学图片库/ Getty Images</p><p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> <a href="https://web.archive.org/web/20220323143059/https://www.prellisbio.com/" target="_blank" rel="noopener">开发 3D 打印器官工具的公司 Prellis Biologics </a>周三宣布了 1450 万美元的 B 轮融资。Prellis 花了数年时间发展组织工程能力，但最近专注于开发一种特殊类型的结构。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">到目前为止，Prellis </span> <a href="https://web.archive.org/web/20220323143059/https://techcrunch.com/2019/08/11/3d-printing-organs-moves-a-few-more-steps-closer-to-commercialization/"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">已经将</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">的重点放在 3D 打印血管支架上，这将允许公司培养健康和氧化的人体器官(或微型版本，称为类器官)，用于药物测试，并最终进行移植。但该公司最近推出了一款新产品，名为 EXIS(外化免疫系统的缩写):一种实验室培养的人类淋巴结。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">淋巴结是人体免疫系统的重要组成部分，它们储存某些免疫细胞，并帮助身体产生免疫反应。理想情况下，这些淋巴结类器官将通过模拟人的免疫系统对新治疗的反应来帮助药物开发。或许，在此过程中还能帮助创造一些新药。</span></p>
<p class="translated">创始人兼首席执行官 Melanie Matheu 告诉 TechCrunch:“通过在培养皿中创建这种免疫系统，我们实际上可以测试这些疗法在进入人体之前是否会引发免疫反应。”</p>
<p class="translated">“我们公司的优势在于[EXIS]是完全人性化的。”</p>
<p class="translated">Prellis Biologics 成立于 2016 年，迄今已筹集了约 2950 万美元。这轮 B 轮由 Celesta Capital 和现有投资者 Khosla Ventures 领投，SOSV IndieBio 参与其中。此外，该公司将增加凯文·查普曼，塞莱斯特顾问和前首席科学官伯克利灯，作为首席科学官。J &amp; J Innovation 的前员工 Yelda Kaya 将加入，担任首席商务官。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">淋巴结对药物或病原体的反应</span> <a href="https://web.archive.org/web/20220323143059/https://www.frontiersin.org/articles/10.3389/fphar.2021.711307/full#h2" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">已经被认为是</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">预测整个免疫系统可能如何反应的一种方式。相应地，有许多学术实验室致力于开发人类淋巴结的体外模型——从芯片上的</span> <a href="https://web.archive.org/web/20220323143059/https://www.frontiersin.org/articles/10.3389/fphar.2021.711307/full#h3" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">淋巴结</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">到从</span> <a href="https://web.archive.org/web/20220323143059/https://www.nature.com/articles/s41591-020-01145-0#Sec10" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">扁桃体组织</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">生长的淋巴器官。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">prel is 通过使用其支架来促进生长功能性淋巴结器官所需的氧气和营养交换，从而加入了竞争。Matheu 说，这种方法允许 Prellis“在人体外复制人类免疫系统。”</span></p>
<p class="translated">这种对淋巴结的关注反过来为公司开辟了一个新的角度:抗体药物开发。</p>
<p class="translated">开发新的抗体疗法并预测它们在临床测试中的效果正成为一个更具竞争力的领域，有几种不同的方法正在进行中。</p>
<p class="translated">有些是计算性的。刚刚融资 1100 万美元的 Nabla Bio，已经使用 <a href="https://web.archive.org/web/20220323143059/https://techcrunch.com/2021/12/07/nabla-bio-raises-11m-for-an-end-to-end-antibody-design-platform/"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">自然语言处理来设计抗体</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">。Generate Bio，也就是刚刚融资了一个</span><a href="https://web.archive.org/web/20220323143059/https://techcrunch.com/2021/11/18/generate-biomedicines-raises-370m-series-b-with-a-focus-on-protein-based-drugs/"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">【3.7 亿美元的 B 轮</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">，也采用了机器学习的方式。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Prellis 的方法是在微型模型中模拟免疫系统，并通过挖掘免疫反应开发候选药物。马修称之为“自然智能”，与人工智能相对。</span></p>
<p class="translated">该公司可以从一次抽血中创造 1200 个类器官，用特定的抗原挑战这些免疫系统，并观察每个免疫系统会产生什么。她说，这个过程可以在具有不同免疫系统特征的不同献血者身上进行，以产生大量的反应进行分析。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“非常罕见的是，所有 10 个人都将拿出相同的抗体来解决这个问题:</span> <i> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">它会结合这个蛋白质</span> </i> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">？因此，从一个给定的人身上，我们平均有 500 到 2000 个独特的抗体，然后你把它乘以人数，这些都是目标结合抗体。”</span></p>
<p class="translated">根据 Prellis Biologics 提供的材料，从抽血到“抗体库”大约需要 18 天。</p>
<p/><div id="attachment_2247300" class="wp-caption aligncenter amp-wp-cdd641a" data-amp-original-style="width: 1536px"><amp-img aria-describedby="caption-attachment-2247300" class="wp-image-2247300 size-full amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png" alt="" srcset="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png 1526w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=150,32 150w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=300,65 300w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=768,166 768w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=680,147 680w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=50,11 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-2247300" loading="lazy" class="wp-image-2247300 size-full" src="../Images/6d8bf5cc4654a2933bf60b2d9026161e.png" alt="" srcset="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png 1526w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=150,32 150w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=300,65 300w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=768,166 768w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=680,147 680w, https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png?resize=50,11 50w" sizes="(max-width: 1526px) 100vw, 1526px" data-original-src="https://web.archive.org/web/20220323143059im_/https://techcrunch.com/wp-content/uploads/2021/12/image-3.png"/></noscript></amp-img><p id="caption-attachment-2247300" class="wp-caption-text translated"><strong>图片来源:</strong> Prellis <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">生物制品</span></p></div>
<p class="translated">Matheu 表示，该公司已经开发出了针对新型冠状病毒、甲型流感和 T2 马尔堡出血热的抗体(这些结果尚未公布)。该公司正在与五家制药公司发展合作关系，但 Matheu 拒绝透露具体是哪几家。</p>
<p class="translated">该公司计划利用这一轮从研发驱动型公司转变为以产品为中心的公司，这意味着发展更多的药物合作伙伴关系，并展示该平台的能力。</p>
<p class="translated">她说，成功的主要标志是将抗体疗法引入临床。这可能通过与制药合作伙伴的合作来实现，尽管该公司没有排除建立自己的药物管道。</p>
<p class="translated">Matheu 没有透露细节，但是他说 Prellis 正在开发“内部技术”来支持治疗管道。</p>
<p class="translated">她说:“我会说，随着技术的发展，我们将朝着那个方向前进。</p>
<p> </p>
<p class="translated">*本故事已经更新，以反映 Prellis 正在与制药公司发展合作关系，但尚未达成合作关系，并提及投资者 SOSV IndieBio。</p>

		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20220323143059im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
		<amp-pixel src="https://web.archive.org/web/20220323143059im_/https://pixel.wp.com/g.gif?v=ext&amp;j=1%3A10.7&amp;blog=136296444&amp;post=2247290&amp;tz=-7&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
	<amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>